US Bancorp
HITK

US Bancorp’s HI-TECH PHARMACAL INC HITK Stock Holding History

US Bancorp’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-6,200
Closed -$268K – 3553
2013
Q3 		$268K Hold
6,200
– – ﹤0.01% 1538
2013
Q2 		$206K Buy
+6,200
New +$206K ﹤0.01% 1625

Other funds holding HITK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

US Bancorp's HITK Position: Q4 2013 in Review

US Bancorp sold out of HI-TECH PHARMACAL INC (HITK) in Q4 2013, closing a stake of 6,200 shares — an estimated $268K sold.

US Bancorp first reported a position in HITK in Q2 2013 and held it in 2 quarters. The position peaked at $268K in Q3 2013. 101 funds tracked by Wall St. Rank hold HITK as of Q4 2013.

  • US Bancorp reported no remaining HI-TECH PHARMACAL INC position as of Q4 2013 after selling out during the quarter.
  • US Bancorp sold 6,200 HI-TECH PHARMACAL INC shares in Q4 2013, an estimated $268K.
  • US Bancorp first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 2 quarters.
  • US Bancorp's HI-TECH PHARMACAL INC position peaked at $268K in Q3 2013.
  • 101 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q4 2013.

Based on US Bancorp's 13F filing for Q4 2013, filed 13 Feb 2014.